Effect Of Education On Adherence, Self Care And Well-Being Of Patients With Chronic Kidney Disease

December 15, 2025 updated by: Lale Yacan, Trakya University

ABSTRACT Aim: The aim of the study was evaluate the effect of education provided to patients diagnosed with chronic kidney disease on adherence to illness, self-care, and well-being.

Design: A randomised controlled trial. Participants: The study sample consisted of total of 119 individuals diagnosed with stage 3 to stage 4 chronic kidney disease.

Methods: The data were collected with the Patient Information Form, Adaptation to Chronic Illness Scale, Self-Care Management Process in Chronic Illness and the World Health Organization-5 Well-Being Index. The data were evaluated using descriptive analyses, the Mann-Whitney U test, Pearson's chi-square test, Fisher-Freeman test, student's t-test, Wilcoxon test, and Friedman test.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Implications for the profession or patient care: This study contributes to the improvement of disease adaptation and self-care of individuals with stage 3 and stage chronic kidney disease.

Reporting Method: Consolidated Standards of Reporting Trials (CONSORT) Patient or Public Contribution: The study sample consisted of total of 119 individuals diagnosed with stage 3 to stage 4 chronic kidney disease.

Study Type

Interventional

Enrollment (Actual)

119

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Centre
      • Edirne, Centre, Turkey (Türkiye), 22030
        • Trakya University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • being over 18 years of age
  • having stage 3 or stage 4 chronic kidney disease
  • not having communication difficulties
  • receiving outpatient treatment at the nephrology outpatient clinic
  • and volunteering to take part in the research

Exclusion Criteria:

  • being under 18 years of age
  • having stage 1, 2 or stage 5 chronic kidney disease
  • having communication difficulties
  • not volunteering to take part in the research
  • receiving hemodialysis or peritoneal dialysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Effect of education on adherence, self care and well-being of patients with chronic kidney disease
Patients who diagnosed with stage 3 to stage 4 chronic kidney disease
Device: Educational with chronic kidney disease
Education Booklet for Patients with Chronic Kidney Disease It was prepared by the researchers in line with the literature review to be used as educational material for patients with stage 3 and stage 4 chronic kidney disease. The education booklet includes information about the kidneys (anatomy and functions of the kidneys), chronic kidney disease (definition of chronic kidney disease , risk factors, symptoms, nutrition in chronic kidney disease , salt consumption, the importance of potassium and phosphorus for our body, regular and balanced nutrition, exercise, the relationship between chronic kidney disease and diabetes, and the relationship between chronic kidney disease and hypertension), and treatment methods (hemodialysis, peritoneal dialysis, and kidney transplant).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adaptation to Chronic Illness Scale
Time Frame: through study completion, an average of 19 months
Adaptation to Chronic Illness Scale (ACIS): The scale includes 25 items, and a total score of 125 points is obtained from the scale. An increase in the scores from the subscales and/or the overall scale means that patients' adaptation levels to illness also increase.
through study completion, an average of 19 months
The Self-Care Management Process in Chronic Illness (SCMP-G)
Time Frame: through study completion, an average of 19 months
The Self-Care Management Process in Chronic Illness (SCMP-G): The scale includes 35 items and is evaluated as 5 (Strongly Agree) and 1 (Strongly Disagree). Self-care management increases with the increasing score on the scale.
through study completion, an average of 19 months
WHO-5 Well-Being Index
Time Frame: through study completion, an average of 19 months
WHO-5 Well-Being Index: The raw score is computed by summing the numbers belonging to 5 answers. Zero represents the worst possible quality of life, while 25 represents the best possible quality of life. To acquire a percentage score ranging from 0 to 100, the raw score is multiplied by 4. Whereas "zero percent" indicates the worst possible quality of life, "one hundred percent" indicates the best possible quality of life.
through study completion, an average of 19 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Trakya University

Investigators

  • Study Director: Özgül Erol, Professor, Trakya University
  • Principal Investigator: Lale Yacan, Trakya University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2020

Primary Completion (Actual)

October 29, 2021

Study Completion (Actual)

August 29, 2022

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

December 15, 2025

First Posted (Actual)

December 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 15, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TUTF-BAEK 2019/206

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Kidney Disease (Stage 3-4)

Clinical Trials on Educational with chronic kidney disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe